Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
Bevacizumab in advanced breast cancer: a new model for the assessment of activity in non-first-line treatment regimens. [electronic resource] by
- Haba-Rodríguez, Juan De la
- González, Antonio
- Cortés, Javier
- Rodríguez-Lescure, Álvaro
- Sánchez, Alfonso
- Pulido, Gema
- Cortijo, Ana
- Guirado, María
- Torrejón, Davis
- Alba, Emilio
Producer: 20140318
In:
Anti-cancer drugs vol. 24
Availability: No items available.
|
|
17.
|
Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer. [electronic resource] by
- Guerrero, Antonio
- Servitja, Sonia
- Rodríguez-Lescure, Alvaro
- Calvo, Lourdes
- del Barco, Sonia
- Quintanar, María Teresa
- Juárez, José Ignacio
- Gayo, Javier
- Llombart, Antonio
- Tusquets, Ignasi
Producer: 20110823
In:
Anti-cancer drugs vol. 22
Availability: No items available.
|
|
18.
|
Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study. [electronic resource] by
- Garrigós, Noemi
- Gallego, Javier
- Guillén-Ponce, Carmen
- Guaraz, Patricia
- García-Bautista, Miriam
- Castillejo, Adela
- Gómez-Martínez, Angeles
- Carrato, Alfredo
- Rodríguez-Lescure, Alvaro
- Soto, José L
Producer: 20100427
In:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico vol. 12
Availability: No items available.
|
|
19.
|
|
|
20.
|
Evidence-based use of taxanes in the adjuvant setting of breast cancer. A review of randomized phase III trials. [electronic resource] by
- Estévez, Laura G
- Muñoz, Montserrat
- Alvarez, Isabel
- Fernández, Yolanda
- García-Mata, Jesús
- Ruiz-Borrego, Manuel
- Tusquets, Ignasi
- Seguí, Miguel Angel
- Rodríguez-Lescure, Alvaro
- Adrover, Encarna
- Lluch, Ana
Producer: 20071030
In:
Cancer treatment reviews vol. 33
Availability: No items available.
|